UBS Group »

Exagen shares owned by UBS Group

Quarter-by-quarter ownership of Exagen (XGN) shares owned by UBS Group from 13F filings

Historical chart of UBS Group investment in Exagen

Tip: Access up to 7 years of quarterly data

All positions including Exagen held by UBS Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Exagen by UBS Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $124k 62k 1.99
2023-09-30 $317k 131k 2.42
2023-06-30 $379k 131k 2.90
2023-03-31 $318k 131k 2.43
2022-12-31 $328k 137k 2.40
2022-09-30 $361k 137k 2.64
2022-06-30 $756k 132k 5.74
2022-03-31 $1.1M 132k 8.03
2021-12-31 $1.6M 136k 11.63
2021-09-30 $1.8M 130k 13.60
2021-06-30 $1.9M 129k 14.99
2021-03-31 $2.3M 133k 17.50
2020-12-31 $11k 860 12.79
2020-09-30 $0 45 0.00
2020-06-30 $19k 1.5k 12.57
2020-03-31 $31k 1.9k 16.10
2019-12-31 $104k 4.1k 25.43